Taken together, these data support a model wherein EC-derived SPARCL1 induces an inflammatory response by triggering the polarization of M1-like macrophages and/or inhibiting the transformation of M2 macrophages, thereby promoting the persistence of inflammation that contributes to the exacerbation of pneumonia. Here, SPARCL1 is linked to susceptibility to pneumonia measurement.